Hiv-1 peptides, nucleic acids, and compositions, and uses thereof
AssigneeRutgers, The State University of New Jersey
InventorAbraham Pinter
Life of this patent
Estimating the term…
Loading patent…
AssigneeRutgers, The State University of New Jersey
InventorAbraham Pinter
Estimating the term…
This invention features polypeptides, variants thereof, and fragments thereof useful in eliciting an immune response (e.g., neutralizing antibodies) against a broad spectrum of HIV-1 isolates. The polypeptides, variants, and fragments include a portion of the gp120 V2 domain of HIV-1. The polypeptides, variants, and fragments display an epitope that is recognized by at least one antibody which neutralizes at least one HIV-1 primary isolate. This invention also features nucleic acid sequences encoding those polypeptides. In addition, the invention provides methods of screening for inhibitors of HIV-1 entry into cells, as well as methods of treatment using the inhibitors.
1-32. (canceled)
An antibody which binds a polypeptide comprising:
Dependencies are inferred from the claim text.